Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions
- PMID: 16897584
- DOI: 10.1007/s11046-006-0026-9
Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions
Abstract
The aspartate proteinase inhibitor pepstatin A was used to study a possible correlation among proteinase activity and other virulence factors of Candida albicans strains isolated from the vaginal environment of patients in three different clinical conditions: asympthomatic, vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC). The addition of 1.0 muM pepstatin A did not have any significant effect on hyphae formation, biofilm production and in the cell surface hydrofobicity of isolates in the three different clinical conditions. However, pepstatin A reduced the adherence of C. albicans to vaginal mucosa epithelial cells (53.1, 48.7 and 59.9%, respectively to isolates from asymptomatic, VVC and RVVC patients). This result suggests that the secreted aspartate proteinases (Saps) of this fungal pathogen may have auxiliary roles in cellular adhesion.
Similar articles
-
Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.Mycoses. 2007 Sep;50(5):383-90. doi: 10.1111/j.1439-0507.2007.01384.x. Mycoses. 2007. PMID: 17714358
-
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.Med Mycol. 2012 Aug;50(6):585-93. doi: 10.3109/13693786.2012.662597. Epub 2012 Feb 28. Med Mycol. 2012. PMID: 22369624
-
Characterization of virulence factors of vaginal and anal isolates of Candida albicans sequentially obtained from patients with vulvovaginal candidiasis in north-east Brazil.J Mycol Med. 2017 Dec;27(4):567-572. doi: 10.1016/j.mycmed.2017.06.002. Epub 2017 Aug 26. J Mycol Med. 2017. PMID: 28844452
-
Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections.Curr Protein Pept Sci. 2017;18(10):1050-1062. doi: 10.2174/1389203717666160809155749. Curr Protein Pept Sci. 2017. PMID: 27514853 Review.
-
Candida vaginitis: virulence, host response and vaccine prospects.Med Mycol. 2018 Apr 1;56(suppl_1):26-31. doi: 10.1093/mmy/myx139. Med Mycol. 2018. PMID: 29538739 Review.
Cited by
-
Virulence Factors as Promoters of Chronic Vulvovaginal Candidosis: A Review.Mycopathologia. 2021 Dec;186(6):755-773. doi: 10.1007/s11046-021-00592-8. Epub 2021 Oct 6. Mycopathologia. 2021. PMID: 34613569 Review.
-
Effect of Carum carvi essential oil on ERG6 gene expression and virulence factors in Candida albicans.Curr Med Mycol. 2020 Jun;6(2):30-36. doi: 10.18502/CMM.6.2.3628. Curr Med Mycol. 2020. PMID: 33628979 Free PMC article.
-
Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies.Mycopathologia. 2008 Jul;166(1):47-50. doi: 10.1007/s11046-008-9119-y. Epub 2008 Apr 29. Mycopathologia. 2008. PMID: 18443923 Review.
-
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.mBio. 2015 Jun 2;6(3):e00724. doi: 10.1128/mBio.00724-15. mBio. 2015. PMID: 26037125 Free PMC article.
-
Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors.Front Microbiol. 2018 Jun 29;9:1383. doi: 10.3389/fmicb.2018.01383. eCollection 2018. Front Microbiol. 2018. PMID: 30008700 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources